香草防蚊 "蛙声阵阵，蝉鸣声声。"一年当中最热的时节登场了。夏至时节，骄阳似火，雨水频繁，人体皮肤 外露的时间明显延长，日晒损伤不说，蚊虫叮咬也令人不堪其扰。今天，中医科与皮肤科的医生就为大 家准备了一份护肤防蚊指南，请注意查收。 此外，还可外用炉甘石、薄荷脑、苯海拉明等止痒剂。若红肿明显，可适当冰敷，外用中效或弱效 激素类药物，如氢化可的松乳膏、糠酸莫米松乳膏等。 不过，若是局部有水疱或破溃，或者出现发热等不适，要及时到医院就诊。但最重要的提醒就是， 不要搔抓刺激。 食香养生 夏至属"火"，苦味食物有助降火。此时节，饮食配合苦菊、生菜等凉拌蔬菜，或饮用荷叶粥、绿豆 汤，能从内调节湿热体质。苦菊的微苦可清热泻火，生菜富含纤维助脾胃运化湿浊，荷叶粥借荷花的清 芳之气升发脾胃阳气，绿豆汤则是经典的解暑佳品。 夏季食物水分大，纤维含量高，而且很多自带芳香，清爽可口，就如同体内的"灭火剂"，当湿热之 邪随尿液排出，人体不再成为吸引蚊虫的"湿热温床"，自然也能减少叮咬困扰，让您安度盛夏。 古人有用香囊驱邪避秽的智慧，至今仍具妙用，可随身携带或放置居室中。取藿香、佩兰各10克， 橘皮、薄荷、豆蔻、丁香各5克，装入透气布袋 ...

Core Viewpoint - Hangzhou Tianmu Mountain Pharmaceutical Co., Ltd. (Tianmu Pharmaceutical) has successfully ended its "ST" status after being delisted from risk warnings by the Shanghai Stock Exchange, marking a significant turnaround in its performance following the acquisition by Qingdao Laoshang State-owned Assets [1][3] Company Overview - Tianmu Pharmaceutical, established in 1958 and listed in 1993, has faced numerous challenges over its 30-year history, including governance issues and financial losses, leading to its stock being under risk warnings since June 2020 [2][3] - The company was acquired by Qingdao Huilong Huaze Investment Co., Ltd. in August 2023, which became the new controlling shareholder, providing a much-needed capital infusion of over 1.1 billion yuan for a 29.99% stake [3][4] Financial Performance - Following the acquisition, Tianmu Pharmaceutical's revenue is projected to grow by 78.44% to 217 million yuan in 2024, with a net profit turnaround to 15.25 million yuan [4] - In the first quarter of the current year, the company reported an 88.55% increase in revenue, surpassing 5 million yuan in net profit [4] Strategic Initiatives - The new management has implemented several measures, including waiving 90 million yuan in debt and providing over 100 million yuan in bank credit guarantees, which have positively impacted the company's operations [4] - Tianmu Pharmaceutical is pursuing a dual-center strategy, consolidating its traditional business in Hangzhou while establishing a northern sales center in Qingdao to expand into the Shandong and North China markets [4] Industry Context - The revitalization of Tianmu Pharmaceutical is seen as beneficial for the pharmaceutical and health industry in Laoshang District, which aims to leverage the company's brand to stimulate broader industry growth [5] - The company is actively exploring new avenues in the health industry, transitioning towards a "Chinese medicine + health" model and aiming for an integrated approach in research, production, and sales [5]

1 | -1-10 | 言 | | --- | --- | | 黑体加粗 | 回询函所列问题 | | 宋体 | 对问询函所列问题的回复 | | 楷体加粗 | 涉及对招股说明书修改的内容 | 2 3 | 序 | 客户/供应商 | 客户 | 交易 | | | 交易金额(万元) | | | --- | --- | --- | --- | --- | --- | --- | --- | | 号 | 名称" | 类型 | 类型 | 具体内容 | 2022年度 | 2021 年度 | 2020 年度 | | 1 | 上海口隆香料 | 贸易商 | 销售 | 凉味剂 WS-3、 WS-12、代加 | 581.73 | 895.12 | 1.898.57 | | | 有限公司 | | | 工收入等 | | | | | | | | 采购 | 薄荷脑等 | 43.08 | 368.66 | 1,258.52 | | 2 | 上海龙师香精 香料有限公司 | | 销售 | 原味剂 WS-3, | 74.27 | 124.88 | 59.25 | | | | 贸易商 | | WS-23 等 | | | | | | | | 采购 | 2. ...